# Non-Narcotic Pain Control After ACL Reconstruction

> **NCT06973785** · PHASE3 · RECRUITING · sponsor: **The Cleveland Clinic** · enrollment: 30 (estimated)

## Conditions studied

- ACL - Anterior Cruciate Ligament Rupture
- ACL Injuries

## Interventions

- **DRUG:** dispense of study drug
- **DRUG:** Ketorolac

## Key facts

- **NCT ID:** NCT06973785
- **Lead sponsor:** The Cleveland Clinic
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-07-15
- **Primary completion:** 2026-09-30
- **Final completion:** 2026-12-31
- **Target enrollment:** 30 (ESTIMATED)
- **Last updated:** 2025-08-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06973785

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06973785, "Non-Narcotic Pain Control After ACL Reconstruction". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06973785. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*